Michael Deucher is a Cardiology physician. OpenAlex indexes 5 publications with 371 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7255 Old Oak Blvd
Ste C208
Cleveland, OH 441303300
Telephone
440-816-2708Registry record last updated 11 Dec 2018.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20259 payments
- Alnylam Pharmaceuticals Inc.Program year20252 payments
- Philips North America LLCProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.5%Beta blocker22.7%Metoprolol Succinate47%Metoprolol Tartrate29%Carvedilol8%Atenolol8%Nebivolol Hcl5%Propranolol Hcl1%Bisoprolol Fumarate1%Sotalol1%Labetalol Hcl1%Nadolol0%Part D<11 patientsStatin13.8%Atorvastatin Calcium52%Rosuvastatin Calcium31%Simvastatin11%Pravastatin Sodium5%Lovastatin1%Part D<11 patients+ 20 more classes in this area
Blood & clotting
16.3%Factor Xa inhibitor9.5%Eliquis72%Xarelto28%Part D≥222 patientsP2Y12 inhibitor4.5%Clopidogrel97%Brilinta3%Part D<11 patients+ 2 more classes in this area
Nervous system
2%SSRI1.9%Sertraline Hcl70%Trazodone Hcl15%Paroxetine Hcl9%Escitalopram Oxalate6%Part D<11 patientsNonsteroidal Anti-inflammatory Drug0.2%Meloxicam100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Targeted cardiac expression of soluble Fas prevents the development of heart failure in mice with cardiac-specific expression of MCP-1
Journal of Molecular and Cellular Cardiology
2006 - HIV-1 infection and AIDS dementia are influenced by a mutant <i>MCP-1</i> allele linked to increased monocyte infiltration of tissues and MCP-1 levels
Proceedings of the National Academy of Sciences
2002 - Monocyte Chemotactic Protein 1 Upregulates IL-1β Expression in Human Monocytes
Biochemical and Biophysical Research Communications
2000 - Clinical assessment of myocardial dysfunction in targeted expression of MCP-1 in the murine heart
Journal of Cardiac Failure
1999
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”